156 related articles for article (PubMed ID: 14151253)
1. NEWER ANTICANCER AGENTS.
KNOCK FE
Med Clin North Am; 1964 Mar; 48():501-27. PubMed ID: 14151253
[No Abstract] [Full Text] [Related]
2. CURRENT STATUS OF CHEMOTHERAPY OF CANCER.
KREMENTZ ET; KOKAME GM; IGLESIAS F
Postgrad Med; 1964 Apr; 35():384-94. PubMed ID: 14131637
[No Abstract] [Full Text] [Related]
3. DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
GOLDENBERG DM
Dis Chest; 1963 Dec; 51():191-208. PubMed ID: 14102116
[No Abstract] [Full Text] [Related]
4. INTERACTION BETWEEN 5-HYDROXYTRYPTAMINE AND ANTITUMOURAL DRUGS.
PALMA V; REYERS-DEGLIINNOCENTI I; GARATTINI S
J Pharm Pharmacol; 1964 Nov; 16():770-1. PubMed ID: 14241150
[No Abstract] [Full Text] [Related]
5. OBSERVATIONS ON THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH MYCOSIS FUNGOIDES.
WRIGHT JC; LYONS MM; WALKER DG; GOLOMB FM; GUMPORT SL; MEDREK TJ
Cancer; 1964 Aug; 17():1045-62. PubMed ID: 14202592
[No Abstract] [Full Text] [Related]
6. [MEDICAL THERAPY OF MALIGNANT NEOPLASMS].
SULLI G
Clin Ter; 1964 Feb; 28():354-84. PubMed ID: 14138272
[No Abstract] [Full Text] [Related]
7. Chemotherapy of malignant disease. I. Solid tumours.
REEVE TS
Med J Aust; 1962 Dec; 49(2)():867-70. PubMed ID: 13973605
[No Abstract] [Full Text] [Related]
8. BLOOD AND URINE LEVELS OF ANTITUMOR AGENTS DETERMINED WITH CELL CULTURE METHODS.
SMITH CG; GRADY JE; KUPIECKI FP
Cancer Res; 1965 Feb; 25():241-5. PubMed ID: 14264057
[No Abstract] [Full Text] [Related]
9. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
SAKURAI Y
Natl Cancer Inst Monogr; 1964 Dec; 16():207-39. PubMed ID: 14235655
[No Abstract] [Full Text] [Related]
10. [EVALUATION OF THE CURRENT THERAPEUTIC TRENDS IN HODGKIN'S DISEASE. CRITICAL REVIEW AND CASUISTIC CONTRIBUTION].
TAGLIORETTI D; TESTERO S; TISO R; ERIDANI S
Arch Patol Clin Med; 1963 Aug; 40():3-32. PubMed ID: 14058830
[No Abstract] [Full Text] [Related]
11. CHEMOTHERAPY OF BREAST CANCER.
SILVA AR; SMART CR; ROCHLIN DB
Surg Gynecol Obstet; 1965 Sep; 121():494-8. PubMed ID: 14332883
[No Abstract] [Full Text] [Related]
12. CHEMOTHERAPY STUDIES ON PRIMARY TUMOR GRAFTS AND METASTASES IN HAMSTERS AND MICE.
HANDLER AH; SARRIS TG; WILLS C
Acta Unio Int Contra Cancrum; 1964; 20():176-9. PubMed ID: 14151878
[No Abstract] [Full Text] [Related]
13. MECHANISMS OF RESISTANCE TO ANTICANCER AGENTS.
BROCKMAN RW
Adv Cancer Res; 1963; 7():129-234. PubMed ID: 14153765
[No Abstract] [Full Text] [Related]
14. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
KONDO T
Acta Unio Int Contra Cancrum; 1964; 20():194-8. PubMed ID: 14151882
[No Abstract] [Full Text] [Related]
15. [Detection of a moderate staphylococcal phage by means of antineoplastic agents].
Smolianskaia AZ; Leĭkina FI
Antibiotiki; 1970 Jun; 15(6):514-9. PubMed ID: 4195833
[No Abstract] [Full Text] [Related]
16. CHEMOTHERAPY STUDIES WITH VIRUS-INDUCED LEUKEMIA IN MICE.
GOLDIN A; GLYNN JP; MOLONEY JB; HUMPHREYS SR; CHIRIGOS MA
Acta Unio Int Contra Cancrum; 1964; 20():157-61. PubMed ID: 14151874
[No Abstract] [Full Text] [Related]
17. NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
SAMPEY JR
Med Times; 1964 Jun; 92():571-4. PubMed ID: 14147083
[No Abstract] [Full Text] [Related]
18. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.
BERENBAUM MC; BROWN IN
Immunology; 1964 Jan; 7(1):65-71. PubMed ID: 14113077
[TBL] [Abstract][Full Text] [Related]
19. SOME PROBLEMS IN THE CHEMOTHERAPY OF SOLID TUMOURS.
ARONOVITCH M; GROSZMAN M; KAHANA LM
Can Med Assoc J; 1964 Mar; 90(11):678-84. PubMed ID: 14127380
[TBL] [Abstract][Full Text] [Related]
20. Single-agent therapy for Hodgkin's disease.
Carter SK; Livingston RB
Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
[No Abstract] [Full Text] [Related]
[Next] [New Search]